Show Notes
A deep dive into the aggressive, curative-intent management of stage IV colorectal cancer with distant metastasis, fueled by an average 40% 5-year overall survival rate for resectable liver metastases. The discussion centers on critical decision points, including sequencing for resectable synchronous metastases (neo-adjuvant chemo is preferred for high-volume disease to assess tumor biology). For liver lesions, modern resectability hinges on achieving R0 clearance and preserving an adequate Future Liver Remnant (FLR). Techniques like ALPPS (Associating Liver Partition and Portal vein Ligation for Staged hepatectomy) are shown to provide a massive 20-month survival advantage over conventional staging. Also reviewed is the management of symptomatic primary tumors (bleeding/obstruction), where endoscopic stenting is a key strategy for palliation in incurable disease.
More from Colorectal Surgery Review
The newly published 2025 ASCRS guidelines for appendiceal neoplasms represent a total departure from traditional surgical dogma, revealing a 16% risk of concealed malignancy in patients presenting with periappendiceal abscesses. This mandates strict oncologic follow-up after initial antibiotic therapy and percutaneous drainage. Beyond the appendix, this episode explores the etiology, staging, and treatment algorithms for anal squamous cell carcinoma. Driven by HPV (specifically serotypes 16 and 18) within the anal transitional zone (ATZ), anal cancer requires a distinct management approach far different from colorectal adenocarcinoma.
Welcome to Colorectal Surgery Review. In this episode, we deliver a high-yield clinical breakdown of the American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines for the Management of Colon Cancer. Designed for practicing colon and rectal surgeons, surgical oncologists, general surgeons, and senior trainees preparing for board certification or recertification exams, this deep dive translates complex trial data, molecular insights, and guideline recommendations into actionable clinical decision-making.
Join us for an in-depth clinical review of the 2022 American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula. In this episode, we break down the latest evidence-based algorithms, anatomical pearls, surgical techniques, and clinical pitfalls needed for surgical practice and board exam preparation.
Join us for a comprehensive clinical review of the American Society of Colon and Rectal Surgeons (ASCRS) Clinical Practice Guidelines for the Management of Anal Fissures. In this episode, we move beyond basic definitions to examine the vascular mechanics, randomized trial data, and surgical algorithms needed to break the cycle of internal sphincter hypertonia and ischemia. Whether you are updating your clinical practice or prepping for board exams, this evidence-based review delivers high-yield insights.
A clinical deep dive into the 2022 and 2023 ASCRS and SAGES guidelines for Enhanced Recovery After Surgery (ERAS). We cover carbohydrate loading, bowel prep, SSI bundles, fluid management, the NSAID leak debate, and early discharge. Join us for an evidence-based clinical review of the 2022 and 2023 American Society of Colon and Rectal Surgeons (ASCRS) and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Clinical Practice Guidelines for Enhanced Recovery After Surgery (ERAS). In this episode, we move past basic ERAS concepts to explore the precise physiological mechanisms, statistical realities, and trial data driving modern perioperative care. Whether you are updating hospital protocols or prepping for your board exams, this review delivers the high-yield details you need.